Medtronic (MDT) Income from Non-Controlling Interests (2016 - 2026)
Medtronic's (MDT) quarterly Income from Non-Controlling Interests came in at $9.0 million in Q3 2026, up 28.57% year-over-year from $7.0 million in Q3 2025, and down 43.75% quarter-over-quarter from $16.0 million in Q2 2026.
Analysis
Medtronic (MDT) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends
Medtronic has disclosed Income from Non-Controlling Interests across 11 years of filings, most recently posting $9.0 million for Q3 2026.
- In Q3 2026, Income from Non-Controlling Interests rose 28.57% year-over-year to $9.0 million; the TTM figure through Jul 2026 stood at $38.0 million (up 26.67% YoY), while the FY2026 annual figure was $37.0 million, up 27.59% from the prior year.
- Income from Non-Controlling Interests came in at $9.0 million for Q3 2026 at Medtronic, down from $16.0 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $16.0 million in Q2 2026 to a low of $2.0 million in Q3 2022.
- Average Income from Non-Controlling Interests over 5 years is $7.2 million, with a median of $6.0 million recorded in 2022.
- Year-over-year, Income from Non-Controlling Interests tumbled 75.0% in 2023 and soared 350.0% in 2024.
- Over 5 years, Income from Non-Controlling Interests stood at $8.0 million in 2022, then plunged by 75.0% to $2.0 million in 2023, then soared by 350.0% to $9.0 million in 2024, then fell by 22.22% to $7.0 million in 2025, then increased by 28.57% to $9.0 million in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $9.0 million in Q3 2026, $16.0 million in Q2 2026, and $6.0 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.16 Bn | 179.56 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.38 Bn | 119.16 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.06 Bn | 101.58 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.75 Bn | 66.21 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.55 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 9.00 Mn |
| Apr 24, 2026 | 16.00 Mn |
| Jan 23, 2026 | 6.00 Mn |
| Oct 24, 2025 | 7.00 Mn |
| Jul 25, 2025 | 7.00 Mn |
| Apr 25, 2025 | 5.00 Mn |
| Jan 24, 2025 | 9.00 Mn |
| Oct 25, 2024 | 9.00 Mn |
| Jul 26, 2024 | 6.00 Mn |
| Apr 26, 2024 | 5.00 Mn |
| Jan 26, 2024 | 15.00 Mn |
| Oct 27, 2023 | 2.00 Mn |
| Jul 28, 2023 | 6.00 Mn |
| Apr 28, 2023 | 9.00 Mn |
| Jan 27, 2023 | 6.00 Mn |
| Oct 28, 2022 | 8.00 Mn |
| Jul 29, 2022 | 2.00 Mn |
| Apr 29, 2022 | 6.00 Mn |
| Jan 28, 2022 | 4.00 Mn |
| Oct 29, 2021 | 6.00 Mn |